Status:
WITHDRAWN
Validation of a New Hand Held Light Emitting Diode Device for the Determination of Minimal Erythema Dose (MED)
Lead Sponsor:
Henry Ford Health System
Conditions:
Phototherapy
Eligibility:
All Genders
18-120 years
Phase:
NA
Brief Summary
The purpose of this study is to validate a new hand held light emitting diode (LED) device for the measurement of minimal erythema dose (MED) for narrow band Ultraviolet B (UVB) radiation by comparing...
Eligibility Criteria
Inclusion
- 1\. Age greater than 18 years.
Exclusion
- Pregnancy
- Lactation
- History of photosensitivity disorder
- Photosensitizing medications
- Personal history of melanoma or non-melanoma skin cancer.
- Skin disease on the back
Key Trial Info
Start Date :
May 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01818154
Start Date
May 1 2012
End Date
December 1 2013
Last Update
March 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henry Ford Medical Center Department of Dermatology
Detroit, Michigan, United States, 48202